World endocrinology news
https://doi.org/10.14341/omet2008245-54
Abstract
The role of interleukin-6 in insulin resistance, body fat distribution and energy balance Disorders of glucose metabolism and risk of oral cancer. Duration of lactation is associated with lower prevalence of the metabolic syndrome in midlife--SWAN, the study of women's health across the nation. Vitamin D deficiency and risk of cardiovascular disease. Adypocyte prolactin: regulation of release and putative functions.
References
1. Obesity reviews (2008) 9, 20-29
2. Hoene M., Weigert C. The role of interleukin-6 in insulin resistence, body fat distribution and energy balance. Obesity reviews 2008;9:20-29.
3. Chien KL, Chen MF, Hsu HC, Chang WT, Su TC, Lee YT, Hu FB. Plasma uric acid and the risk of type 2 diabetes in a Chinese community. Clin Chem. 2008 Feb;54(2):310-6.
4. Suba Z, Ujpa l M. Disorders of glucose metabolism and risk of oral cancer. Fogorv Sz. 2007 Oct;100(5):250-7, 243-9
5. Ram KT, Bobby P, Hailpern SM, Lo JC, Schocken M, Skurnick J, Santoro N. Duration of lactation is associated with lower prevalence of the metabolic syndrome in midlife--SWAN, the study of women's health across the nation. Am J Obstet Gynecol. 2008;198(3):268.e1-6.
6. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M, Vasan RS. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117(4):503-11.
7. Brandebourg T., Hugo E., Ben-Jonathan N. Adypocyte prolactin: regulation of release and putative functions. Diabetes, Obesity and Metabolism, 9, 2007, 464-476
8. Scott R, d’Emden M, Best J, et al; on behalf of the FIELD Investigators. Features of metabolic syndrome identify individuals with type 2 diabetes melli- tus at high risk for cardiovascular events and greater absolute benefits of fenofibrate. Circulation 2007;116(Suppl II):838 (abstract 3691).
9. Burgess D, Hunt D, Li LP, et al; on behalf of the FIELD Investigators. Effects of fenofibrate on silent myocardial infarction, hospitalization for acute coronary syn- dromes and amputation in type 2 diabetes: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Circulation 2007;116(Suppl II):838 (abstract 3693).
Review
For citations:
Berkovskaya M.A. World endocrinology news. Obesity and metabolism. 2008;5(2):45-54. (In Russ.) https://doi.org/10.14341/omet2008245-54
Views:
434
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
